News and Views
Nature Neuroscience 11, 124 - 126 (2008)
doi:10.1038/nn0208-124
Why endocannabinoids are not all alike
Vincenzo Di Marzo1 & Luigia Cristino1
- Vincenzo Di Marzo is at the Endocannabinoid Research Group, Istituto di Chimica Biomolecolare and Luigia Cristino is at the Istituto di Cibernetica, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, Comprensorio Olivetti, 80078, Pozzuoli (NA), Italy. e-mail: vdimarzo@icmib.na.cnr.it
Abstract
New work in this issue shows that one principal endocannabinoid, anandamide, directly inhibits the synthesis of another, 2-arachidonoylglycerol. This finding could explain a number of puzzling observations in the endocannabinoid field.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism Original Article
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatumNature Neuroscience Article (01 Feb 2008)
Endocannabinoids in Chronic Migraine: CSF Findings Suggest a System FailureNeuropsychopharmacology Original Article
See all 14 matches for Research
